Dogwood Therapeutics (NASDAQ:DWTX) Trading Up 15.6% – Still a Buy?

Dogwood Therapeutics, Inc. (NASDAQ:DWTX) shares rose 15.6% during mid-day trading on Thursday . The stock traded as high as $7.16 and last traded at $6.83. Approximately 218,034 shares changed hands during mid-day trading, a decline of 89% from the average daily volume of 2,020,999 shares. The stock had previously closed at $5.91.

Dogwood Therapeutics Stock Down 7.3 %

The stock has a market cap of $8.43 million, a price-to-earnings ratio of -0.97 and a beta of 2.07. The business has a fifty day moving average price of $7.28.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Dogwood Therapeutics stock. Geode Capital Management LLC purchased a new position in Dogwood Therapeutics, Inc. (NASDAQ:DWTX) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 10,933 shares of the company’s stock, valued at approximately $27,000. Geode Capital Management LLC owned about 0.82% of Dogwood Therapeutics at the end of the most recent quarter. Institutional investors own 9.05% of the company’s stock.

About Dogwood Therapeutics

Dogwood Therapeutics, Inc is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia.